A Real-world Study of Anti-PD-1 Antibody Combination Therapy in Advanced Hepatocellular Carcinoma

A Real-world Study of Anti-PD-1 Antibody Combination Therapy in Advanced Hepatocellular Carcinoma

Objective To explore the efficacy, safety, and factors that might influence the efficacy of antiPD-1 antibody-based therapy in advanced hepatocellular carcinoma in the real world. Methods The clinical features, efficacy, and safety in patients with advanced hepatocellular carcinoma who received anti...

Full description

Bibliographic Details
Main Authors: QIAO Shishi, KONG Tiandong, YU Dan, YANG Zhen, PAN Yanfeng, ZHAO Lingdi
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2023-03-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
hepatocellular carcinoma
anti-pd-1 antibody
liver function
performance status
real world
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.0852

Internet

http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.0852

Similar Items